1. What is Sahajanand Medical Technologies IPO?
Sahajanand Medical Technologies Limited is a medical
technology company that manufactures specialised
cardiovascular and vascular intervention devices.
2. When will the IPO open and close?
Reported dates are 15 October 2026 to 19 October 2026.
Please verify these dates against the final offer
document and official exchange announcements.
3. What is the IPO price band?
The reported price range is ₹327–₹344 per share.
Check the final offer document to confirm the official band.
4. What is the IPO lot size?
The supplied lot size is 43 shares. At ₹344 per share,
one lot amounts to ₹14,792, excluding applicable charges.
5. What is the minimum Retail application amount?
Based on the supplied details, the minimum Retail
application is 43 shares for ₹14,792 at ₹344 per share.
6. What are the S-HNI and B-HNI minimum amounts?
Based on the supplied table, S-HNI minimum is ₹2,07,088
for 602 shares and B-HNI minimum is ₹10,05,856 for
2,924 shares.
7. What does Sahajanand Medical Technologies do?
The company develops and manufactures devices such as
coronary stents, drug-coated balloons and products used
in structural heart procedures.
8. Is this a Fresh Issue or an Offer for Sale?
Available issue information describes an Offer for Sale.
Under an OFS, proceeds go to selling shareholders rather
than directly to the company. Verify the final structure.
9. Where will the shares be listed?
The proposed listing is on NSE and BSE, subject to
final documents and exchange approvals.
10. What are the key risks of this IPO?
Key risks may include regulatory compliance, competition,
product quality, borrowings, market acceptance and valuation.
Investors should read the risk factors in the offer document.
11. How can I check the allotment status?
Check the official registrar or exchange website once
allotment is finalised. You can also visit
Chittorgarh IPO Details
for updates.
12. Should I invest in this IPO?
Investors should review the company's financials,
valuation, offer document, risks and their own investment
objectives before making an independent decision.
